Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Robert Sheneberger"'
1321. The UNZA/UMB MMed ID Collaboration: Training and Retaining HIV Specialist Physicians in Zambia
Autor:
Christopher M. Bositis, Lottie Hachaambwa, Izukanji Sikazwe, Cassidy W. Claassen, Douglas C. Watson, Robert Sheneberger, Lloyd Mulenga, Devang Patel, Nason Lambwe
Publikováno v:
Open Forum Infectious Diseases
Background To mitigate the HIV pandemic and increasing outbreaks of infectious diseases, sub-Saharan African countries need increased healthcare worker capacity at all levels. We describe a successful collaboration between the Ministry of Health (MOH
Autor:
Mark J. Giganti, Priscilla L. Mulenga, Peter Mwaba, Stewart E Reid, Robert Sheneberger, Jeffrey S. A. Stringer, Lloyd Mulenga, Benjamin H. Chi, Elizabeth M. Stringer, Carolyn Bolton-Moore, Namwinga Chintu, Albert Mwango, Bushimbwa Tambatamba-Chapula
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 54:63-70
BACKGROUND In July 2007, amid some controversy over cost, Zambia was the first African country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a wide scale. METHODS We compared drug substitutions, mortality,
Autor:
Victor Enejoh, A. Nwandu, Babatunji Oni, Winifred Stanis-Ezeobi, Ejike Nwene, Lotte Hachaambwa, Robert R. Redfield, Ignace Gashongore, Robert Sheneberger, Yvonne Brown-Henley, Peter Memiah, Anthony Edozien, Chidi Nwizu, George Anthony Loy, Joseph F. O'Neill, Olivia Dix, Folaju O Oyebola, Mei Ching Lee, Peter Maro, Martine Etienne-Mesubi, Cyprien Baribwira, Gregory Pappas, Devang Patel, Vicki Tepper, Athanase Kiromera, Anthony Amoroso, Carla Alexander, Mope Shimabale, Guesley Delva, Angela Kaiza-Kangalawe, Michael Obiefune
Publikováno v:
Journal of pain and symptom management. 50(3)
Palliative care (PC), introduced early in the management of chronic illness, improves patient outcomes. Early integration of a palliative approach for persons with HIV has been documented to be effective in identifying and managing patient-level conc
Autor:
Jelita Chinyonga, Bridget Mugisa, Ignace Gashongore, Cassidy W. Claassen, Robert Sheneberger, Kebby Musokotwane
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 74:96
Autor:
Brian G. Williams, Alex Welte, Stéphane Verguet, Wim Delva, John W. Hargrove, Tienie Stander, Robert Sheneberger
Publikováno v:
AIDS. 25:1435-1437
Autor:
Anthony Edozien, Michael Obiefune, Robert Sheneberger, Robert R. Redfield, Kristen A Stafford, Anthony Amoroso, Mian B. Hossain, Martine Etienne-Mesubi, Sylvia Ojoo
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 60(3)
BACKGROUND: Although used globally little data exist on the efficacy of nevirapine (NVP) used in combination with tenofovir (TDF)/emtricitabine or lamivudine (XTC) and no large randomized prospective control trials exists comparing this combination w
Autor:
Linnaea Schuttner, Robert Sheneberger, Carolyn Bolton-Moore, Elizabeth M. Stringer, Namwinga Chintu, Crispin Moyo, Izukanji Sikazwe, Mark J. Giganti, Albert Mwango, Lloyd Mulenga, Benjamin H. Chi, Jeffrey S. A. Stringer
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 58(5)
Although tenofovir (TDF) is a common component of antiretroviral therapy (ART), recent evidence suggests inferior outcomes when it is combined with nevirapine (NVP).We compared outcomes among patients initiating TDF + emtricitabine or lamivudine (XTC
Autor:
Julio S. G. Montaner, Alex Welte, Wim Delva, Victor Dukay, David Ginsburg, John W. Hargrove, Robert Sheneberger, Brian G. Williams, Robin Wood, Martinus Stander
Publikováno v:
Journal of the International AIDS Society
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Potent antiretroviral therapy (ART) reduces mortality and morbidity in people living with HIV by reducing viral load and allowing their immune systems to recover. The reduction in viral load soon after starting ART has led to the hypothesis that earl